Morning Overview on MSN
Molecular switch lets cancer cells dodge death
Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged ...
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need ...
Researchers have identified a stress-activated control mechanism that helps breast cancer cells reshape gene activity to ...
Scientists at NYU Langone discovered that blocking a key protein that shields cancer cells from a natural stress-driven death process can dramatically slow lung tumor growth.
Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...
Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...
The footprint of death (also referred to as FOOD in the study) may help guide the immune cells to the exact spot to clear ...
News-Medical.Net on MSN
Drug combination can bypass cellular defenses in neuroblastoma
A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence.
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...
Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results